{"product_id":"nad-500mg-vial","title":"NAD+ 500mg vial","description":"\u003cp class=\"\" data-end=\"740\" data-start=\"485\"\u003e\u003cstrong data-end=\"529\" data-start=\"485\"\u003e\u003cspan style=\"color: #ff2a00;\"\u003e\u003cstrong\u003e                                                    \u003cspan style=\"text-decoration: underline;\"\u003eNOT \u003c\/span\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cspan style=\"color: #ff2a00; text-decoration: underline;\"\u003e\u003cstrong\u003eFOR HUMAN CONSUMPTION\u003cmeta charset=\"UTF-8\"\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"38\" data-end=\"1056\"\u003e\u003cstrong\u003eNicotinamide adenine dinucleotide\u003c\/strong\u003e (\u003cstrong data-start=\"106\" data-end=\"114\"\u003eNAD⁺\u003c\/strong\u003e) is a universal redox cofactor and enzyme substrate central to \u003cstrong data-start=\"178\" data-end=\"211\"\u003eenergy metabolism (NAD⁺\/NADH)\u003c\/strong\u003e and \u003cstrong data-start=\"216\" data-end=\"235\"\u003ecell signalling\u003c\/strong\u003e. As a co-substrate, NAD⁺ fuels \u003cstrong data-start=\"267\" data-end=\"289\"\u003esirtuins (SIRT1–7)\u003c\/strong\u003e, \u003cstrong data-start=\"291\" data-end=\"300\"\u003ePARPs\u003c\/strong\u003e, \u003cstrong data-start=\"302\" data-end=\"316\"\u003eCD38\/CD157\u003c\/strong\u003e, and \u003cstrong data-start=\"322\" data-end=\"331\"\u003eSARM1\u003c\/strong\u003e, thereby governing mitochondrial biogenesis, DNA repair, circadian timing, immune tone, and axon integrity. Tissue NAD⁺ falls with aging and cardiometabolic stress due to \u003cstrong data-start=\"503\" data-end=\"541\"\u003eincreased consumption (PARPs\/CD38)\u003c\/strong\u003e and \u003cstrong data-start=\"546\" data-end=\"566\"\u003eimpaired salvage\u003c\/strong\u003e. Augmentation strategies include \u003cstrong data-start=\"600\" data-end=\"622\"\u003edietary precursors\u003c\/strong\u003e (nicotinamide riboside, NR; nicotinamide mononucleotide, NMN; niacin\/NA; nicotinamide\/NAM; tryptophan→kynurenine pathway), \u003cstrong data-start=\"746\" data-end=\"766\"\u003eenzyme targeting\u003c\/strong\u003e (boost \u003cstrong data-start=\"774\" data-end=\"783\"\u003eNAMPT\u003c\/strong\u003e, inhibit \u003cstrong data-start=\"793\" data-end=\"806\"\u003eCD38\/PARP\u003c\/strong\u003e), and \u003cstrong data-start=\"813\" data-end=\"832\"\u003eparenteral NAD⁺\u003c\/strong\u003e (investigational). No NAD⁺-raising therapy is \u003cstrong data-start=\"879\" data-end=\"899\"\u003eFDA\/EMA-approved\u003c\/strong\u003e for disease modification; \u003cstrong data-start=\"926\" data-end=\"932\"\u003eNR\u003c\/strong\u003e is widely sold as a supplement; \u003cstrong data-start=\"965\" data-end=\"972\"\u003eNMN\u003c\/strong\u003e has \u003cstrong data-start=\"977\" data-end=\"1007\"\u003evariable regulatory status\u003c\/strong\u003e by country; \u003cstrong data-start=\"1020\" data-end=\"1031\"\u003eIV NAD⁺\u003c\/strong\u003e is not an approved drug.\u003c\/p\u003e\n\u003chr data-start=\"1058\" data-end=\"1061\"\u003e\n\u003ch3 data-start=\"1063\" data-end=\"1128\"\u003eAdditional Benefits of NAD⁺ Repletion Now Under Investigation\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"_tableWrapper_1rjym_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"1130\" data-end=\"3337\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"1130\" data-end=\"1158\"\u003e\n\u003ctr data-start=\"1130\" data-end=\"1158\"\u003e\n\u003cth data-start=\"1130\" data-end=\"1140\" data-col-size=\"md\"\u003eBenefit\u003c\/th\u003e\n\u003cth data-start=\"1140\" data-end=\"1158\" data-col-size=\"xl\"\u003eKey take-aways\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"1169\" data-end=\"3337\"\u003e\n\u003ctr data-start=\"1169\" data-end=\"1417\"\u003e\n\u003ctd data-start=\"1169\" data-end=\"1206\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"1171\" data-end=\"1205\"\u003e1 Mitochondrial function \u0026amp; ATP\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"1206\" data-end=\"1417\" data-col-size=\"xl\"\u003eNAD⁺ restoration increases \u003cstrong data-start=\"1235\" data-end=\"1251\"\u003eSIRT1\/PGC-1α\u003c\/strong\u003e activity, \u003cstrong data-start=\"1262\" data-end=\"1272\"\u003eOXPHOS\u003c\/strong\u003e proteins, and \u003cstrong data-start=\"1287\" data-end=\"1315\"\u003emitochondrial biogenesis\u003c\/strong\u003e, improving skeletal-muscle oxidative capacity. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Cell Metabolism; Nature Communications\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"1418\" data-end=\"1658\"\u003e\n\u003ctd data-start=\"1418\" data-end=\"1470\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"1420\" data-end=\"1469\"\u003e2 Insulin sensitivity \u0026amp; metabolic flexibility\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"1470\" data-end=\"1658\" data-col-size=\"xl\"\u003eIn overweight adults, \u003cstrong data-start=\"1494\" data-end=\"1501\"\u003eNMN\u003c\/strong\u003e improved \u003cstrong data-start=\"1511\" data-end=\"1541\"\u003emuscle insulin sensitivity\u003c\/strong\u003e without weight loss; NR shows \u003cstrong data-start=\"1572\" data-end=\"1607\"\u003emodest glycaemic\/lipid benefits\u003c\/strong\u003e in some cohorts. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Science; Diabetes\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"1659\" data-end=\"1870\"\u003e\n\u003ctd data-start=\"1659\" data-end=\"1682\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"1661\" data-end=\"1681\"\u003e3 Vascular aging\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"1682\" data-end=\"1870\" data-col-size=\"xl\"\u003e\n\u003cstrong data-start=\"1684\" data-end=\"1690\"\u003eNR\u003c\/strong\u003e increased \u003cstrong data-start=\"1701\" data-end=\"1721\"\u003ewhole-blood NAD⁺\u003c\/strong\u003e and reduced \u003cstrong data-start=\"1734\" data-end=\"1764\"\u003eaortic stiffness\/clinic BP\u003c\/strong\u003e in mid-life adults with elevated cardiovascular risk. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Nature Communications; Hypertension\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"1871\" data-end=\"2095\"\u003e\n\u003ctd data-start=\"1871\" data-end=\"1897\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"1873\" data-end=\"1896\"\u003e4 Liver fat \u0026amp; NAFLD\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"1897\" data-end=\"2095\" data-col-size=\"xl\"\u003ePreclinical and pilot human studies suggest \u003cstrong data-start=\"1943\" data-end=\"1970\"\u003elower hepatic steatosis\u003c\/strong\u003e, \u003cstrong data-start=\"1972\" data-end=\"1996\"\u003eALT\/AST improvements\u003c\/strong\u003e, and reduced \u003cstrong data-start=\"2010\" data-end=\"2025\"\u003elipogenesis\u003c\/strong\u003e with NAD⁺ precursors. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Hepatology; Liver International\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"2096\" data-end=\"2384\"\u003e\n\u003ctd data-start=\"2096\" data-end=\"2132\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"2098\" data-end=\"2131\"\u003e5 Neuroprotection \u0026amp; cognition\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"2132\" data-end=\"2384\" data-col-size=\"xl\"\u003eNAD⁺ supports \u003cstrong data-start=\"2148\" data-end=\"2185\"\u003eaxonal survival (SARM1 restraint)\u003c\/strong\u003e, \u003cstrong data-start=\"2187\" data-end=\"2210\"\u003esynaptic plasticity\u003c\/strong\u003e, and \u003cstrong data-start=\"2216\" data-end=\"2241\"\u003emitochondrial quality\u003c\/strong\u003e; small trials report signals in \u003cstrong data-start=\"2274\" data-end=\"2293\"\u003esleep\/cognition\u003c\/strong\u003e and \u003cstrong data-start=\"2298\" data-end=\"2319\"\u003eneurodegenerative\u003c\/strong\u003e contexts. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Neuron; Journal of Alzheimer’s Disease\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"2385\" data-end=\"2658\"\u003e\n\u003ctd data-start=\"2385\" data-end=\"2425\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"2387\" data-end=\"2424\"\u003e6 Exercise performance \u0026amp; recovery\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"2425\" data-end=\"2658\" data-col-size=\"xl\"\u003eIncreased \u003cstrong data-start=\"2437\" data-end=\"2448\"\u003eVO₂peak\u003c\/strong\u003e and \u003cstrong data-start=\"2453\" data-end=\"2485\"\u003efatty-acid oxidation markers\u003c\/strong\u003e with NR\/NMN in some studies; others are neutral—benefits may depend on \u003cstrong data-start=\"2557\" data-end=\"2586\"\u003ebaseline fitness and dose\u003c\/strong\u003e. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Medicine \u0026amp; Science in Sports \u0026amp; Exercise; FASEB Journal\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"2659\" data-end=\"2894\"\u003e\n\u003ctd data-start=\"2659\" data-end=\"2691\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"2661\" data-end=\"2690\"\u003e7 Kidney \u0026amp; cardiac stress\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"2691\" data-end=\"2894\" data-col-size=\"xl\"\u003eNAD⁺ repletion mitigates \u003cstrong data-start=\"2718\" data-end=\"2741\"\u003eAKI\/CKD progression\u003c\/strong\u003e and \u003cstrong data-start=\"2746\" data-end=\"2783\"\u003epost-ischemic cardiac dysfunction\u003c\/strong\u003e in models via \u003cstrong data-start=\"2798\" data-end=\"2830\"\u003eDNA-repair and mitochondrial\u003c\/strong\u003e pathways. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Nature Medicine; Circulation Research\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"2895\" data-end=\"3122\"\u003e\n\u003ctd data-start=\"2895\" data-end=\"2936\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"2897\" data-end=\"2935\"\u003e8 Immune resilience \u0026amp; inflammation\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"2936\" data-end=\"3122\" data-col-size=\"xl\"\u003eBy modulating \u003cstrong data-start=\"2952\" data-end=\"2965\"\u003eCD38\/PARP\u003c\/strong\u003e and SIRT networks, NAD⁺ can \u003cstrong data-start=\"2994\" data-end=\"3025\"\u003ereduce inflammaging markers\u003c\/strong\u003e and enhance \u003cstrong data-start=\"3038\" data-end=\"3061\"\u003eantiviral responses\u003c\/strong\u003e; human data are early. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Immunity; Geroscience\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"3123\" data-end=\"3337\"\u003e\n\u003ctd data-start=\"3123\" data-end=\"3154\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"3125\" data-end=\"3153\"\u003e9 Skin \u0026amp; barrier biology\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"3154\" data-end=\"3337\" data-col-size=\"xl\"\u003eTopical\/oral precursors improve \u003cstrong data-start=\"3188\" data-end=\"3206\"\u003ebarrier lipids\u003c\/strong\u003e, \u003cstrong data-start=\"3208\" data-end=\"3232\"\u003ecollagen transcripts\u003c\/strong\u003e, and \u003cstrong data-start=\"3238\" data-end=\"3260\"\u003eUV-repair capacity\u003c\/strong\u003e; cosmetic endpoints show benefit. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Dermatology; Redox Biology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"3339\" data-end=\"3342\"\u003e\n\u003ch2 data-start=\"3344\" data-end=\"3379\"\u003e2. Molecular Mechanism of Action\u003c\/h2\u003e\n\u003ch3 data-start=\"3381\" data-end=\"3414\"\u003e2.1 Enzyme Pharmacodynamics\u003c\/h3\u003e\n\u003cul data-start=\"3415\" data-end=\"3944\"\u003e\n\u003cli data-start=\"3415\" data-end=\"3569\"\u003e\n\u003cp data-start=\"3417\" data-end=\"3569\"\u003e\u003cstrong data-start=\"3417\" data-end=\"3440\"\u003eSirtuins (SIRT1–7):\u003c\/strong\u003e NAD⁺-dependent deacylases → \u003cstrong data-start=\"3469\" data-end=\"3490\"\u003ePGC-1α activation\u003c\/strong\u003e, mitochondrial biogenesis, \u003cstrong data-start=\"3518\" data-end=\"3537\"\u003eNF-κB dampening\u003c\/strong\u003e, improved insulin signalling.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3570\" data-end=\"3709\"\u003e\n\u003cp data-start=\"3572\" data-end=\"3709\"\u003e\u003cstrong data-start=\"3572\" data-end=\"3592\"\u003ePARPs (PARP1\/2):\u003c\/strong\u003e DNA-damage sensors; high activity \u003cstrong data-start=\"3627\" data-end=\"3644\"\u003econsumes NAD⁺\u003c\/strong\u003e and limits ATP; controlled activity supports genome stability.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3710\" data-end=\"3824\"\u003e\n\u003cp data-start=\"3712\" data-end=\"3824\"\u003e\u003cstrong data-start=\"3712\" data-end=\"3727\"\u003eCD38\/CD157:\u003c\/strong\u003e Ecto-enzymes that \u003cstrong data-start=\"3746\" data-end=\"3764\"\u003ehydrolyze NAD⁺\u003c\/strong\u003e to cyclic\/linear ADPR; upregulated with age\/inflammation.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3825\" data-end=\"3944\"\u003e\n\u003cp data-start=\"3827\" data-end=\"3944\"\u003e\u003cstrong data-start=\"3827\" data-end=\"3837\"\u003eSARM1:\u003c\/strong\u003e Pro-degenerative axonal NADase; inhibition\/offset by higher \u003cstrong data-start=\"3898\" data-end=\"3907\"\u003eNMNAT\u003c\/strong\u003e and \u003cstrong data-start=\"3912\" data-end=\"3920\"\u003eNAD⁺\u003c\/strong\u003e supports axon survival.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-start=\"3946\" data-end=\"3981\"\u003e2.2 Upstream\/Downstream Biology\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"_tableWrapper_1rjym_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"3983\" data-end=\"4442\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"3983\" data-end=\"4022\"\u003e\n\u003ctr data-start=\"3983\" data-end=\"4022\"\u003e\n\u003cth data-start=\"3983\" data-end=\"3992\" data-col-size=\"sm\"\u003eModule\u003c\/th\u003e\n\u003cth data-start=\"3992\" data-end=\"4013\" data-col-size=\"md\"\u003eFunctional outcome\u003c\/th\u003e\n\u003cth data-start=\"4013\" data-end=\"4022\" data-col-size=\"sm\"\u003eNotes\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"4037\" data-end=\"4442\"\u003e\n\u003ctr data-start=\"4037\" data-end=\"4159\"\u003e\n\u003ctd data-start=\"4037\" data-end=\"4081\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"4039\" data-end=\"4080\"\u003eSalvage (NAM→NMN→NAD⁺; NAMPT, NMNATs)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"4081\" data-end=\"4128\" data-col-size=\"md\"\u003eMaintains cytosolic\/mitochondrial NAD⁺ pools\u003c\/td\u003e\n\u003ctd data-start=\"4128\" data-end=\"4159\" data-col-size=\"sm\"\u003e\n\u003cstrong data-start=\"4130\" data-end=\"4137\"\u003eNRK\u003c\/strong\u003e converts \u003cstrong data-start=\"4147\" data-end=\"4157\"\u003eNR→NMN\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"4160\" data-end=\"4263\"\u003e\n\u003ctd data-start=\"4160\" data-end=\"4187\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"4162\" data-end=\"4186\"\u003eDe novo (Trp→Kyn→QA)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"4187\" data-end=\"4235\" data-col-size=\"md\"\u003eBackup NAD⁺ supply; inflammation diverts flux\u003c\/td\u003e\n\u003ctd data-start=\"4235\" data-end=\"4263\" data-col-size=\"sm\"\u003eKynurenines immunoactive\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"4264\" data-end=\"4341\"\u003e\n\u003ctd data-start=\"4264\" data-end=\"4288\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"4266\" data-end=\"4287\"\u003eRedox (NAD⁺\/NADH)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"4288\" data-end=\"4314\" data-col-size=\"md\"\u003eGlycolysis\/TCA\/ETC flux\u003c\/td\u003e\n\u003ctd data-start=\"4314\" data-end=\"4341\" data-col-size=\"sm\"\u003eCouples to ROS handling\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"4342\" data-end=\"4442\"\u003e\n\u003ctd data-start=\"4342\" data-end=\"4378\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"4344\" data-end=\"4377\"\u003eCircadian (CLOCK\/BMAL1–SIRT1)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"4378\" data-end=\"4413\" data-col-size=\"md\"\u003eAligns metabolism with day\/night\u003c\/td\u003e\n\u003ctd data-start=\"4413\" data-end=\"4442\" data-col-size=\"sm\"\u003eNAD⁺ oscillates diurnally\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"4444\" data-end=\"4447\"\u003e\n\u003ch2 data-start=\"4449\" data-end=\"4497\"\u003e3. Pharmacokinetics (augmentation strategies)\u003c\/h2\u003e\n\u003cul data-start=\"4499\" data-end=\"5295\"\u003e\n\u003cli data-start=\"4499\" data-end=\"4640\"\u003e\n\u003cp data-start=\"4501\" data-end=\"4640\"\u003e\u003cstrong data-start=\"4501\" data-end=\"4513\"\u003eOral NR:\u003c\/strong\u003e Rapid absorption; increases \u003cstrong data-start=\"4542\" data-end=\"4563\"\u003eblood\/tissue NAD⁺\u003c\/strong\u003e within hours; half-life minutes; excreted as \u003cstrong data-start=\"4609\" data-end=\"4628\"\u003eMeNAM → 2PY\/4PY\u003c\/strong\u003e in urine.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4641\" data-end=\"4821\"\u003e\n\u003cp data-start=\"4643\" data-end=\"4821\"\u003e\u003cstrong data-start=\"4643\" data-end=\"4656\"\u003eOral NMN:\u003c\/strong\u003e Converted to NAD⁺ via \u003cstrong data-start=\"4679\" data-end=\"4692\"\u003eNRK\/NMNAT\u003c\/strong\u003e; a putative \u003cstrong data-start=\"4705\" data-end=\"4716\"\u003eSLC12A8\u003c\/strong\u003e transporter is described in mice; human transport remains debated; raises \u003cstrong data-start=\"4791\" data-end=\"4805\"\u003eblood NAD⁺\u003c\/strong\u003e within hours.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4822\" data-end=\"5036\"\u003e\n\u003cp data-start=\"4824\" data-end=\"5036\"\u003e\u003cstrong data-start=\"4824\" data-end=\"4861\"\u003eNiacin (NA) \/ Nicotinamide (NAM):\u003c\/strong\u003e Classical precursors; \u003cstrong data-start=\"4884\" data-end=\"4890\"\u003eNA\u003c\/strong\u003e causes \u003cstrong data-start=\"4898\" data-end=\"4907\"\u003eflush\u003c\/strong\u003e, improves lipids at pharmacologic doses; \u003cstrong data-start=\"4949\" data-end=\"4956\"\u003eNAM\u003c\/strong\u003e raises NAD⁺ but at high doses increases \u003cstrong data-start=\"4997\" data-end=\"5014\"\u003eMeNAM\/2PY\/4PY\u003c\/strong\u003e (methylation sink).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5037\" data-end=\"5197\"\u003e\n\u003cp data-start=\"5039\" data-end=\"5197\"\u003e\u003cstrong data-start=\"5039\" data-end=\"5069\"\u003eIV NAD⁺ (investigational):\u003c\/strong\u003e Transient plasma rise with downstream \u003cstrong data-start=\"5108\" data-end=\"5121\"\u003eNAM\/MeNAM\u003c\/strong\u003e; intracellular access largely via \u003cstrong data-start=\"5156\" data-end=\"5194\"\u003eextracellular breakdown→precursors\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5198\" data-end=\"5295\"\u003e\n\u003cp data-start=\"5200\" data-end=\"5295\"\u003e\u003cstrong data-start=\"5200\" data-end=\"5214\"\u003eClearance:\u003c\/strong\u003e Predominantly urinary \u003cstrong data-start=\"5237\" data-end=\"5254\"\u003eMeNAM\/2PY\/4PY\u003c\/strong\u003e; high doses tax \u003cstrong data-start=\"5271\" data-end=\"5294\"\u003emethyl donors (SAM)\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"5297\" data-end=\"5300\"\u003e\n\u003ch2 data-start=\"5302\" data-end=\"5347\"\u003e4. Pre-clinical and Translational Evidence\u003c\/h2\u003e\n\u003ch3 data-start=\"5349\" data-end=\"5389\"\u003e4.1 Human trials (selected themes)\u003c\/h3\u003e\n\u003cul data-start=\"5390\" data-end=\"5968\"\u003e\n\u003cli data-start=\"5390\" data-end=\"5554\"\u003e\n\u003cp data-start=\"5392\" data-end=\"5554\"\u003e\u003cstrong data-start=\"5392\" data-end=\"5399\"\u003eNR:\u003c\/strong\u003e In mid-life\/older adults, raises NAD⁺ and \u003cstrong data-start=\"5442\" data-end=\"5473\"\u003ereduces aortic stiffness\/BP\u003c\/strong\u003e; variable effects on insulin sensitivity and lipids; generally well tolerated.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5555\" data-end=\"5695\"\u003e\n\u003cp data-start=\"5557\" data-end=\"5695\"\u003e\u003cstrong data-start=\"5557\" data-end=\"5565\"\u003eNMN:\u003c\/strong\u003e In overweight\/prediabetic adults, \u003cstrong data-start=\"5600\" data-end=\"5639\"\u003eimproved muscle insulin sensitivity\u003c\/strong\u003e and skeletal-muscle NAD⁺ signalling over 10–12 weeks.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5696\" data-end=\"5870\"\u003e\n\u003cp data-start=\"5698\" data-end=\"5870\"\u003e\u003cstrong data-start=\"5698\" data-end=\"5713\"\u003eNiacin\/NAM:\u003c\/strong\u003e Robust lipid effects for \u003cstrong data-start=\"5739\" data-end=\"5749\"\u003eniacin\u003c\/strong\u003e but limited by \u003cstrong data-start=\"5765\" data-end=\"5809\"\u003eflush, insulin resistance, and gout risk\u003c\/strong\u003e; high-dose \u003cstrong data-start=\"5821\" data-end=\"5828\"\u003eNAM\u003c\/strong\u003e limited by \u003cstrong data-start=\"5840\" data-end=\"5854\"\u003eGI\/hepatic\u003c\/strong\u003e tolerability.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5871\" data-end=\"5968\"\u003e\n\u003cp data-start=\"5873\" data-end=\"5968\"\u003e\u003cstrong data-start=\"5873\" data-end=\"5885\"\u003eIV NAD⁺:\u003c\/strong\u003e Used in clinics for wellness\/withdrawal claims; \u003cstrong data-start=\"5934\" data-end=\"5967\"\u003erigorous RCT data are lacking\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cblockquote data-start=\"5970\" data-end=\"6272\"\u003e\n\u003cp data-start=\"5972\" data-end=\"6272\"\u003e\u003cstrong data-start=\"5972\" data-end=\"5998\"\u003eEvidence quality note:\u003c\/strong\u003e Strong \u003cstrong data-start=\"6006\" data-end=\"6021\"\u003emechanistic\u003c\/strong\u003e and \u003cstrong data-start=\"6026\" data-end=\"6036\"\u003eanimal\u003c\/strong\u003e data; \u003cstrong data-start=\"6043\" data-end=\"6057\"\u003ehuman RCTs\u003c\/strong\u003e show reliable \u003cstrong data-start=\"6072\" data-end=\"6098\"\u003ebiochemical NAD⁺ rises\u003c\/strong\u003e and \u003cstrong data-start=\"6103\" data-end=\"6136\"\u003esignal-level clinical effects\u003c\/strong\u003e (vascular\/insulin sensitivity) but \u003cstrong data-start=\"6172\" data-end=\"6189\"\u003emixed results\u003c\/strong\u003e for performance, weight, and hard outcomes. Larger, longer trials are in progress.\u003c\/p\u003e\n\u003c\/blockquote\u003e\n\u003chr data-start=\"6274\" data-end=\"6277\"\u003e\n\u003ch2 data-start=\"6279\" data-end=\"6312\"\u003e5. Emerging Clinical Interests\u003c\/h2\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"_tableWrapper_1rjym_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"6314\" data-end=\"7042\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"6314\" data-end=\"6352\"\u003e\n\u003ctr data-start=\"6314\" data-end=\"6352\"\u003e\n\u003cth data-start=\"6314\" data-end=\"6322\" data-col-size=\"sm\"\u003eField\u003c\/th\u003e\n\u003cth data-start=\"6322\" data-end=\"6334\" data-col-size=\"md\"\u003eRationale\u003c\/th\u003e\n\u003cth data-start=\"6334\" data-end=\"6352\" data-col-size=\"sm\"\u003eCurrent status\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"6367\" data-end=\"7042\"\u003e\n\u003ctr data-start=\"6367\" data-end=\"6457\"\u003e\n\u003ctd data-start=\"6367\" data-end=\"6396\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6369\" data-end=\"6395\"\u003eGeroscience\/sarcopenia\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-start=\"6396\" data-end=\"6432\"\u003eMitochondrial + inflammatory axis\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6432\" data-end=\"6457\"\u003ePhase 2–style signals\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"6458\" data-end=\"6572\"\u003e\n\u003ctd data-start=\"6458\" data-end=\"6485\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6460\" data-end=\"6484\"\u003eCardiometabolic risk\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"6485\" data-end=\"6529\" data-col-size=\"md\"\u003eVascular aging, NAFLD, insulin resistance\u003c\/td\u003e\n\u003ctd data-start=\"6529\" data-end=\"6572\" data-col-size=\"sm\"\u003eMixed RCTs; more powered studies needed\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"6573\" data-end=\"6679\"\u003e\n\u003ctd data-start=\"6573\" data-end=\"6597\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6575\" data-end=\"6596\"\u003eNeurodegeneration\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"6597\" data-end=\"6644\" data-col-size=\"md\"\u003eAxon survival (SARM1), mitochondrial support\u003c\/td\u003e\n\u003ctd data-start=\"6644\" data-end=\"6679\" data-col-size=\"sm\"\u003eEarly human; strong preclinical\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"6680\" data-end=\"6753\"\u003e\n\u003ctd data-start=\"6680\" data-end=\"6704\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6682\" data-end=\"6703\"\u003eKidney injury\/CKD\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-start=\"6704\" data-end=\"6736\"\u003eDNA-repair \u0026amp; metabolic rescue\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6736\" data-end=\"6753\"\u003eTranslational\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"6754\" data-end=\"6866\"\u003e\n\u003ctd data-start=\"6754\" data-end=\"6778\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6756\" data-end=\"6777\"\u003eOncology-adjacent\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"6778\" data-end=\"6825\" data-col-size=\"md\"\u003eSupport normal tissue; complex tumor biology\u003c\/td\u003e\n\u003ctd data-start=\"6825\" data-end=\"6866\" data-col-size=\"sm\"\u003ePreclinical; caution in active cancer\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"6867\" data-end=\"6956\"\u003e\n\u003ctd data-start=\"6867\" data-end=\"6900\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6869\" data-end=\"6899\"\u003eDermatology\/cosmeceuticals\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-start=\"6900\" data-end=\"6929\"\u003eBarrier\/collagen\/UV repair\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6929\" data-end=\"6956\"\u003eSmall trials; cosmetics\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"6957\" data-end=\"7042\"\u003e\n\u003ctd data-start=\"6957\" data-end=\"6987\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6959\" data-end=\"6986\"\u003eCritical illness\/sepsis\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-start=\"6987\" data-end=\"7018\"\u003ePARP overuse \u0026amp; NAD⁺ collapse\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"7018\" data-end=\"7042\"\u003ePilot investigations\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"7044\" data-end=\"7047\"\u003e\n\u003ch2 data-start=\"7049\" data-end=\"7078\"\u003e6. Safety and Tolerability\u003c\/h2\u003e\n\u003cul data-start=\"7080\" data-end=\"8274\"\u003e\n\u003cli data-start=\"7080\" data-end=\"7246\"\u003e\n\u003cp data-start=\"7082\" data-end=\"7246\"\u003e\u003cstrong data-start=\"7082\" data-end=\"7119\"\u003eNR\/NMN (oral, usual trial doses):\u003c\/strong\u003e Generally \u003cstrong data-start=\"7130\" data-end=\"7148\"\u003ewell tolerated\u003c\/strong\u003e (flushing uncommon). \u003cstrong data-start=\"7170\" data-end=\"7182\"\u003eGI upset\u003c\/strong\u003e, \u003cstrong data-start=\"7184\" data-end=\"7196\"\u003eheadache\u003c\/strong\u003e, \u003cstrong data-start=\"7198\" data-end=\"7209\"\u003efatigue\u003c\/strong\u003e, \u003cstrong data-start=\"7211\" data-end=\"7223\"\u003epruritus\u003c\/strong\u003e occur in a minority.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7247\" data-end=\"7429\"\u003e\n\u003cp data-start=\"7249\" data-end=\"7429\"\u003e\u003cstrong data-start=\"7249\" data-end=\"7265\"\u003eNiacin (NA):\u003c\/strong\u003e \u003cstrong data-start=\"7266\" data-end=\"7278\"\u003eFlushing\u003c\/strong\u003e, \u003cstrong data-start=\"7280\" data-end=\"7291\"\u003eitching\u003c\/strong\u003e, \u003cstrong data-start=\"7293\" data-end=\"7308\"\u003ehypotension\u003c\/strong\u003e, \u003cstrong data-start=\"7310\" data-end=\"7330\"\u003e↑ uric acid\/gout\u003c\/strong\u003e, \u003cstrong data-start=\"7332\" data-end=\"7364\"\u003e↑ glucose\/insulin resistance\u003c\/strong\u003e, hepatotoxicity risk (especially \u003cstrong data-start=\"7398\" data-end=\"7419\"\u003esustained-release\u003c\/strong\u003e forms).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7430\" data-end=\"7645\"\u003e\n\u003cp data-start=\"7432\" data-end=\"7645\"\u003e\u003cstrong data-start=\"7432\" data-end=\"7455\"\u003eNicotinamide (NAM):\u003c\/strong\u003e Better tolerated than niacin; \u003cstrong data-start=\"7486\" data-end=\"7504\"\u003ehepatotoxicity\u003c\/strong\u003e at high doses (≥3 g\/day), \u003cstrong data-start=\"7531\" data-end=\"7541\"\u003enausea\u003c\/strong\u003e, \u003cstrong data-start=\"7543\" data-end=\"7555\"\u003eheadache\u003c\/strong\u003e; increases \u003cstrong data-start=\"7567\" data-end=\"7584\"\u003eMeNAM\/2PY\/4PY\u003c\/strong\u003e (methyl-sink)—consider \u003cstrong data-start=\"7608\" data-end=\"7630\"\u003efolate\/B₁₂\/betaine\u003c\/strong\u003e sufficiency.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7646\" data-end=\"7814\"\u003e\n\u003cp data-start=\"7648\" data-end=\"7814\"\u003e\u003cstrong data-start=\"7648\" data-end=\"7660\"\u003eIV NAD⁺:\u003c\/strong\u003e Infusion-rate related \u003cstrong data-start=\"7683\" data-end=\"7737\"\u003enausea, chest\/abdominal tightness, lightheadedness\u003c\/strong\u003e; sterile-prep and monitoring required; \u003cstrong data-start=\"7777\" data-end=\"7811\"\u003eno disease indication approved\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7815\" data-end=\"8274\"\u003e\n\u003cp data-start=\"7817\" data-end=\"7841\"\u003e\u003cstrong data-start=\"7817\" data-end=\"7839\"\u003eBiologic cautions:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-start=\"7844\" data-end=\"8274\"\u003e\n\u003cli data-start=\"7844\" data-end=\"7999\"\u003e\n\u003cp data-start=\"7846\" data-end=\"7999\"\u003e\u003cstrong data-start=\"7846\" data-end=\"7868\"\u003eActive malignancy:\u003c\/strong\u003e Some tumors are \u003cstrong data-start=\"7885\" data-end=\"7908\"\u003eNAMPT\/NAD⁺-addicted\u003c\/strong\u003e; indiscriminate NAD⁺ boosting could be counterproductive—\u003cstrong data-start=\"7966\" data-end=\"7988\"\u003eoncology oversight\u003c\/strong\u003e advised.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"8002\" data-end=\"8141\"\u003e\n\u003cp data-start=\"8004\" data-end=\"8141\"\u003e\u003cstrong data-start=\"8004\" data-end=\"8026\"\u003eDrug interactions:\u003c\/strong\u003e Theoretical with \u003cstrong data-start=\"8044\" data-end=\"8063\"\u003ePARP inhibitors\u003c\/strong\u003e, \u003cstrong data-start=\"8065\" data-end=\"8081\"\u003echemotherapy\u003c\/strong\u003e (DNA-repair), and \u003cstrong data-start=\"8100\" data-end=\"8119\"\u003eimmunotherapies\u003c\/strong\u003e; monitor in trials.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"8144\" data-end=\"8274\"\u003e\n\u003cp data-start=\"8146\" data-end=\"8274\"\u003e\u003cstrong data-start=\"8146\" data-end=\"8169\"\u003eMethylation burden:\u003c\/strong\u003e High \u003cstrong data-start=\"8175\" data-end=\"8185\"\u003eNAM\/NR\u003c\/strong\u003e intake increases methylated metabolites; watch \u003cstrong data-start=\"8233\" data-end=\"8249\"\u003ehomocysteine\u003c\/strong\u003e and methyl-donor status.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"8276\" data-end=\"8305\"\u003e\u003cstrong data-start=\"8276\" data-end=\"8305\"\u003eComparative safety matrix\u003c\/strong\u003e\u003c\/p\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"_tableWrapper_1rjym_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"8307\" data-end=\"9039\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"8307\" data-end=\"8394\"\u003e\n\u003ctr data-start=\"8307\" data-end=\"8394\"\u003e\n\u003cth data-start=\"8307\" data-end=\"8317\" data-col-size=\"sm\"\u003eFeature\u003c\/th\u003e\n\u003cth data-start=\"8317\" data-end=\"8326\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"8319\" data-end=\"8325\"\u003eNR\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-start=\"8326\" data-end=\"8336\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"8328\" data-end=\"8335\"\u003eNMN\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-start=\"8336\" data-end=\"8354\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"8338\" data-end=\"8353\"\u003eNiacin (NA)\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-start=\"8354\" data-end=\"8379\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"8356\" data-end=\"8378\"\u003eNicotinamide (NAM)\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-start=\"8379\" data-end=\"8394\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"8381\" data-end=\"8392\"\u003eIV NAD⁺\u003c\/strong\u003e\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"8421\" data-end=\"9039\"\u003e\n\u003ctr data-start=\"8421\" data-end=\"8511\"\u003e\n\u003ctd data-start=\"8421\" data-end=\"8439\" data-col-size=\"sm\"\u003eHuman NAD⁺ rise\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"8439\" data-end=\"8458\"\u003e\u003cstrong data-start=\"8441\" data-end=\"8457\"\u003eYes (robust)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"8458\" data-end=\"8477\"\u003e\u003cstrong data-start=\"8460\" data-end=\"8476\"\u003eYes (robust)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-start=\"8477\" data-end=\"8483\"\u003eYes\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"8483\" data-end=\"8489\"\u003eYes\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"8489\" data-end=\"8511\"\u003eTransient\/systemic\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"8512\" data-end=\"8681\"\u003e\n\u003ctd data-start=\"8512\" data-end=\"8523\" data-col-size=\"sm\"\u003eKey pros\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"8523\" data-end=\"8564\"\u003eGood GI tolerability; vascular signals\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"8564\" data-end=\"8602\"\u003eInsulin-sensitivity signal; good GI\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-start=\"8602\" data-end=\"8630\"\u003eLipid-lowering (HDL↑ TG↓)\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"8630\" data-end=\"8654\"\u003eNo flush; inexpensive\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"8654\" data-end=\"8681\"\u003eRapid levels; bypass GI\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"8682\" data-end=\"8921\"\u003e\n\u003ctd data-start=\"8682\" data-end=\"8693\" data-col-size=\"sm\"\u003eKey cons\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"8693\" data-end=\"8735\"\u003ePossible \u003cstrong data-start=\"8704\" data-end=\"8720\"\u003eLDL\/TG drift\u003c\/strong\u003e in some; cost\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"8735\" data-end=\"8766\"\u003eRegulatory variability; cost\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-start=\"8766\" data-end=\"8826\"\u003e\n\u003cstrong data-start=\"8768\" data-end=\"8777\"\u003eFlush\u003c\/strong\u003e, \u003cstrong data-start=\"8779\" data-end=\"8791\"\u003eglucose↑\u003c\/strong\u003e, \u003cstrong data-start=\"8793\" data-end=\"8807\"\u003euric acid↑\u003c\/strong\u003e, hepatotoxic (SR)\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"8826\" data-end=\"8873\"\u003e\n\u003cstrong data-start=\"8828\" data-end=\"8846\"\u003eHepatotoxicity\u003c\/strong\u003e at high dose; methyl sink\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"8873\" data-end=\"8921\"\u003eRate-limited AEs; \u003cstrong data-start=\"8893\" data-end=\"8919\"\u003eno approved indication\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"8922\" data-end=\"9039\"\u003e\n\u003ctd data-start=\"8922\" data-end=\"8939\" data-col-size=\"sm\"\u003eEvidence level\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"8939\" data-end=\"8970\"\u003eMultiple small–moderate RCTs\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"8970\" data-end=\"8983\"\u003eEarly RCTs\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-start=\"8983\" data-end=\"9004\"\u003eExtensive (lipids)\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"9004\" data-end=\"9015\"\u003eModerate\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"9015\" data-end=\"9039\"\u003eSparse\/heterogeneous\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"9041\" data-end=\"9044\"\u003e\n\u003ch2 data-start=\"9046\" data-end=\"9072\"\u003e7. Regulatory Landscape\u003c\/h2\u003e\n\u003cul data-start=\"9074\" data-end=\"9508\"\u003e\n\u003cli data-start=\"9074\" data-end=\"9145\"\u003e\n\u003cp data-start=\"9076\" data-end=\"9145\"\u003e\u003cstrong data-start=\"9076\" data-end=\"9095\"\u003eApproved drugs:\u003c\/strong\u003e None for “NAD⁺ repletion” as a disease therapy.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9146\" data-end=\"9292\"\u003e\n\u003cp data-start=\"9148\" data-end=\"9292\"\u003e\u003cstrong data-start=\"9148\" data-end=\"9187\"\u003eDietary supplements (US\/EU varies):\u003c\/strong\u003e \u003cstrong data-start=\"9188\" data-end=\"9194\"\u003eNR\u003c\/strong\u003e broadly marketed; \u003cstrong data-start=\"9213\" data-end=\"9220\"\u003eNMN\u003c\/strong\u003e status \u003cstrong data-start=\"9228\" data-end=\"9248\"\u003evaries\/contested\u003c\/strong\u003e; \u003cstrong data-start=\"9250\" data-end=\"9264\"\u003eniacin\/NAM\u003c\/strong\u003e are established vitamins.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9293\" data-end=\"9396\"\u003e\n\u003cp data-start=\"9295\" data-end=\"9396\"\u003e\u003cstrong data-start=\"9295\" data-end=\"9315\"\u003eParenteral NAD⁺:\u003c\/strong\u003e Not FDA-approved; clinic use is \u003cstrong data-start=\"9348\" data-end=\"9370\"\u003eoff-label\/wellness\u003c\/strong\u003e without disease claims.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9397\" data-end=\"9508\"\u003e\n\u003cp data-start=\"9399\" data-end=\"9508\"\u003e\u003cstrong data-start=\"9399\" data-end=\"9411\"\u003eQuality:\u003c\/strong\u003e Use \u003cstrong data-start=\"9416\" data-end=\"9423\"\u003eGMP\u003c\/strong\u003e sources; third-party testing helps reduce \u003cstrong data-start=\"9466\" data-end=\"9482\"\u003eadulteration\u003c\/strong\u003e and \u003cstrong data-start=\"9487\" data-end=\"9507\"\u003elabel-claim gaps\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"9510\" data-end=\"9513\"\u003e\n\u003ch2 data-start=\"9515\" data-end=\"9538\"\u003e8. Future Directions\u003c\/h2\u003e\n\u003cul data-start=\"9540\" data-end=\"10373\"\u003e\n\u003cli data-start=\"9540\" data-end=\"9724\"\u003e\n\u003cp data-start=\"9542\" data-end=\"9724\"\u003e\u003cstrong data-start=\"9542\" data-end=\"9572\"\u003ePhenotype-targeted trials:\u003c\/strong\u003e Visceral-obese NAFLD, \u003cstrong data-start=\"9595\" data-end=\"9611\"\u003epre-diabetes\u003c\/strong\u003e, \u003cstrong data-start=\"9613\" data-end=\"9629\"\u003ehypertensive\u003c\/strong\u003e mid-life adults, \u003cstrong data-start=\"9647\" data-end=\"9654\"\u003eCKD\u003c\/strong\u003e, and early \u003cstrong data-start=\"9666\" data-end=\"9687\"\u003eneurodegeneration\u003c\/strong\u003e with biomarker-anchored endpoints.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9725\" data-end=\"9922\"\u003e\n\u003cp data-start=\"9727\" data-end=\"9922\"\u003e\u003cstrong data-start=\"9727\" data-end=\"9755\"\u003eMechanism-guided combos:\u003c\/strong\u003e \u003cstrong data-start=\"9756\" data-end=\"9777\"\u003eNR\/NMN + exercise\u003c\/strong\u003e, \u003cstrong data-start=\"9779\" data-end=\"9804\"\u003ecaloric periodization\u003c\/strong\u003e, \u003cstrong data-start=\"9806\" data-end=\"9821\"\u003eSGLT2\/GLP-1\u003c\/strong\u003e co-therapy; \u003cstrong data-start=\"9834\" data-end=\"9853\"\u003eCD38 inhibition\u003c\/strong\u003e to preserve NAD⁺; \u003cstrong data-start=\"9872\" data-end=\"9896\"\u003emethyl-donor support\u003c\/strong\u003e when using high NAM\/NR.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9923\" data-end=\"10022\"\u003e\n\u003cp data-start=\"9925\" data-end=\"10022\"\u003e\u003cstrong data-start=\"9925\" data-end=\"9948\"\u003eOutcome end-points:\u003c\/strong\u003e Hard outcomes (fractures, MACE, CKD progression), not just NAD⁺ levels.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"10023\" data-end=\"10195\"\u003e\n\u003cp data-start=\"10025\" data-end=\"10195\"\u003e\u003cstrong data-start=\"10025\" data-end=\"10052\"\u003eCompartmental NADomics:\u003c\/strong\u003e Distinguish \u003cstrong data-start=\"10065\" data-end=\"10101\"\u003ecytosolic vs mitochondrial pools\u003c\/strong\u003e, tissue targeting, and \u003cstrong data-start=\"10125\" data-end=\"10146\"\u003eclock-time dosing\u003c\/strong\u003e to align with \u003cstrong data-start=\"10161\" data-end=\"10174\"\u003ecircadian\u003c\/strong\u003e NAD⁺ oscillations.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"10196\" data-end=\"10373\"\u003e\n\u003cp data-start=\"10198\" data-end=\"10373\"\u003e\u003cstrong data-start=\"10198\" data-end=\"10217\"\u003eSafety science:\u003c\/strong\u003e Long-term \u003cstrong data-start=\"10228\" data-end=\"10253\"\u003eoncology surveillance\u003c\/strong\u003e, hepatobiliary panels, \u003cstrong data-start=\"10277\" data-end=\"10305\"\u003ehomocysteine\/methylation\u003c\/strong\u003e monitoring at higher doses, and standardized \u003cstrong data-start=\"10351\" data-end=\"10362\"\u003eIV NAD⁺\u003c\/strong\u003e protocols.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"10375\" data-end=\"10378\"\u003e\n\u003ch3 data-start=\"10380\" data-end=\"10403\"\u003eSelected References\u003c\/h3\u003e\n\u003cul data-start=\"10405\" data-end=\"11334\"\u003e\n\u003cli data-start=\"10405\" data-end=\"10501\"\u003e\n\u003cp data-start=\"10407\" data-end=\"10501\"\u003eTrammell S.A.J. et al. Human \u003cstrong data-start=\"10436\" data-end=\"10442\"\u003eNR\u003c\/strong\u003e pharmacokinetics and NAD⁺ metabolome. \u003cem data-start=\"10481\" data-end=\"10498\"\u003eCell Metabolism\u003c\/em\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"10502\" data-end=\"10617\"\u003e\n\u003cp data-start=\"10504\" data-end=\"10617\"\u003eMartens C.R. et al. \u003cstrong data-start=\"10524\" data-end=\"10530\"\u003eNR\u003c\/strong\u003e lowers aortic stiffness and blood pressure in older adults. \u003cem data-start=\"10591\" data-end=\"10614\"\u003eNature Communications\u003c\/em\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"10618\" data-end=\"10709\"\u003e\n\u003cp data-start=\"10620\" data-end=\"10709\"\u003eYoshino J. et al. \u003cstrong data-start=\"10638\" data-end=\"10645\"\u003eNMN\u003c\/strong\u003e improves insulin sensitivity in prediabetic women. \u003cem data-start=\"10697\" data-end=\"10706\"\u003eScience\u003c\/em\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"10710\" data-end=\"10821\"\u003e\n\u003cp data-start=\"10712\" data-end=\"10821\"\u003eMills K.F. et al. NAD⁺ repletion improves mitochondrial function and lifespan in models. \u003cem data-start=\"10801\" data-end=\"10818\"\u003eCell Metabolism\u003c\/em\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"10822\" data-end=\"10942\"\u003e\n\u003cp data-start=\"10824\" data-end=\"10942\"\u003eCamacho-Pereira J. et al. \u003cstrong data-start=\"10850\" data-end=\"10858\"\u003eCD38\u003c\/strong\u003e drives age-related NAD⁺ decline; inhibition restores function. \u003cem data-start=\"10922\" data-end=\"10939\"\u003eNature Medicine\u003c\/em\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"10943\" data-end=\"11025\"\u003e\n\u003cp data-start=\"10945\" data-end=\"11025\"\u003eLautrup S. et al. NAD⁺ in brain aging and disease. \u003cem data-start=\"10996\" data-end=\"11022\"\u003eNature Reviews Neurology\u003c\/em\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"11026\" data-end=\"11125\"\u003e\n\u003cp data-start=\"11028\" data-end=\"11125\"\u003eRajman L., Chwalek K., Sinclair D. Therapeutic potential of NAD⁺ precursors. \u003cem data-start=\"11105\" data-end=\"11122\"\u003eCell Metabolism\u003c\/em\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"11126\" data-end=\"11236\"\u003e\n\u003cp data-start=\"11128\" data-end=\"11236\"\u003eCanto C., Auwerx J. NAD⁺ and sirtuins in metabolic control. \u003cem data-start=\"11188\" data-end=\"11233\"\u003eCold Spring Harbor Perspectives in Medicine\u003c\/em\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"11237\" data-end=\"11334\"\u003e\n\u003cp data-start=\"11239\" data-end=\"11334\"\u003eKatsyuba E., Auwerx J. \u003cstrong data-start=\"11262\" data-end=\"11282\"\u003eNAD⁺ homeostasis\u003c\/strong\u003e: from tryptophan to therapy. \u003cem data-start=\"11312\" data-end=\"11331\"\u003eNature Metabolism\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"\" data-end=\"8819\" data-start=\"8626\"\u003e \u003c\/p\u003e","brand":"RCpeptides","offers":[{"title":"Default Title","offer_id":52684861014354,"sku":"10","price":70.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1048\/0956\/2450\/files\/NAD_500mg.png?v=1770834907","url":"https:\/\/sciencepeptideslab.com\/products\/nad-500mg-vial","provider":"Science Peptides Lab","version":"1.0","type":"link"}